MY173864A - Site-directed modification of fviii - Google Patents

Site-directed modification of fviii

Info

Publication number
MY173864A
MY173864A MYPI2013000709A MYPI2013000709A MY173864A MY 173864 A MY173864 A MY 173864A MY PI2013000709 A MYPI2013000709 A MY PI2013000709A MY PI2013000709 A MYPI2013000709 A MY PI2013000709A MY 173864 A MY173864 A MY 173864A
Authority
MY
Malaysia
Prior art keywords
site
fviii
directed modification
polyethylene glycol
covalently bound
Prior art date
Application number
MYPI2013000709A
Inventor
Clark Q Pan
John E Murphy
Baisong Mei
Jonathan S Strauss
Jianmin Chen
Thomas Barnett
Hendri Tjandra
Liang Tang
Deqian Wang
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Priority to MYPI2013000709A priority Critical patent/MY173864A/en
Publication of MY173864A publication Critical patent/MY173864A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

This invention relates to Factor VIII muteins that are covalently bound, at a predefined site that is not an N-terminal amine, to one or more biocompatible polymers such as polyethylene glycol. The mutein conjugates retain VIII procoagulant activity and have improved pharmacokinetic properties.
MYPI2013000709A 2007-05-18 2007-05-18 Site-directed modification of fviii MY173864A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2013000709A MY173864A (en) 2007-05-18 2007-05-18 Site-directed modification of fviii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2013000709A MY173864A (en) 2007-05-18 2007-05-18 Site-directed modification of fviii

Publications (1)

Publication Number Publication Date
MY173864A true MY173864A (en) 2020-02-25

Family

ID=79170498

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2013000709A MY173864A (en) 2007-05-18 2007-05-18 Site-directed modification of fviii

Country Status (1)

Country Link
MY (1) MY173864A (en)

Similar Documents

Publication Publication Date Title
PH12019501613A1 (en) Site-directed modification of fviii
EP3406347A3 (en) Xten conjugate compositions and methods of making same
ATE479421T1 (en) CATIONIC CONDITIONER
EP1943669A4 (en) Linear and cross-linked high molecular weight polysilanes, polygermanes, and copolymers thereof, compositions containing the same, and methods of making and using such compounds and compositions
MX2007012157A (en) Polymeric micelles for drug delivery.
GB201009493D0 (en) Modified recombinant factor viii and von willebrand factor and methods of use
EA201390600A1 (en) THERAPEUTIC NANOPARTICLES WITH COPOLYMERS WITH A GREAT MOLECULAR WEIGHT
MX2010001955A (en) Polymeric linkers containing pyridyl disulfide moieties.
ATE422880T1 (en) HETEROFUNCTIONAL COPOLYMERS OF GLYCEROL AND POLYETHYLENE GLYCOL, THEIR CONJUGATES AND COMPOSITIONS
MY160922A (en) Polyethylene glycol conjugated blood coagulation factor vii
EP2309990A4 (en) Drug loaded polymeric nanoparticles and methods of making and using same
DE602007012072D1 (en) ORANTAGONISTEN
EP2151461A3 (en) Benzylated polyalkylene polyamines and uses thereof
WO2009141826A3 (en) Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases
WO2007127473A3 (en) Poly (ethylene glycol) containing chemically disparate endgroups
MA34025B1 (en) POLYPEPTIDES BINDING TO BETA-A
DE602007008150D1 (en) TEMPLAT-FIXED PEPTIDOMIMETIKA
MY160510A (en) Polyethylene gycol conjugated blood coagulation factor viia
ATE458740T1 (en) 1,4,5,6,7,8-HEXAHYDRO-1,2,5-TRIAZA-AZULENE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS
WO2011005510A3 (en) Peptide conjugates and uses thereof
BRPI0414008B8 (en) compounds that bind to a thrombopoietin receptor, compositions and in vitro methods for activating a thrombopoietin receptor in a cell
UA93284C2 (en) Peg-g-csp conjugate
MY181129A (en) Site-directed modification of fviii
MY173864A (en) Site-directed modification of fviii
MY151329A (en) Site-directed modification of fviii